In a recent decision upholding the expansive reach of the federal wire fraud statute (18 U.S.C. §1343), the U.S. Supreme Court ruled in Kousisis v. United States, No. 23-909 (May 22, 2025) that a defendant can be convicted of...more
5/29/2025
/ Contract Disputes ,
Criminal Prosecution ,
False Claims Act (FCA) ,
Fraud ,
Fraudulent Inducement ,
General-Business ,
Intent to Defraud ,
Material Misrepresentation ,
Misrepresentation ,
Pass-Through Entities ,
SCOTUS ,
Subcontractors ,
White Collar Crimes ,
Wire Fraud
When I litigated False Claims Act (FCA) cases at the U.S. Department of Justice (DOJ), it was common practice for settlements to require Corporate Integrity Agreements (CIAs) setting forth ongoing duties and responsibilities...more
2/20/2025
/ Compliance ,
Corporate Integrity Agreement ,
Department of Health and Human Services (HHS) ,
Department of Justice (DOJ) ,
False Claims Act (FCA) ,
Fraud ,
Health Care Providers ,
Liability ,
Reverse False Claims ,
Settlement ,
Whistleblowers
In a significant ruling, the Second Circuit Court of Appeals recently expanded the scope of the Anti-Kickback Statute (AKS).The Court joined other circuit courts across the country in adopting, for the first time, the...more
1/8/2025
/ Anti-Kickback Statute ,
Compliance ,
Enforcement ,
Enforcement Actions ,
False Claims Act (FCA) ,
Federal Pleading Requirements ,
Fraud ,
Health Care Providers ,
Healthcare ,
Healthcare Fraud ,
Litigation Strategies ,
Medicare ,
Novartis ,
Pharmaceutical Industry ,
Physicians ,
Prescription Drugs ,
Qui Tam ,
Quid Pro Quo ,
Relators ,
Whistleblowers